The increase in personal genome data generated in diagnostics and research holds great promise for advancing personalized prevention and medicine. However, valuable genomic and associated clinical data is fragmented across many healthcare providers and research organizations, making it difficult to reuse due to lack of findability, accessibility and interoperability. This prohibits us from exploiting the potential information contained in these genomes for health benefit. FAIR Genomes aims to provide guidelines that should increase reuse of genomic data while considering the needs of all stakeholders and addressing ELSI issues. We present a standardized meta-data schema to harmonize genomic data workflows and their reporting practices....